Mon news: AstraZeneca BiTE for follicular lymphoma. Mixed data for Keytruda/Lynparza in ovarian cancer. AbbVie’s Parkinson’s prospect. Merck’s ROR1 drug hits lymphoma target. Half of pharma using AI and big data. —http://bit.ly/w28kSd
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
cafepharma